Industry News
Stop the growth: U-M researchers take aim at cancer metastasis
4/15/2016
Most cancer drugs today work by attacking tumor growth. Researchers at the University of Michigan Life Sciences Institute, however, are taking aim at a different piece of the cancer...
The benefit of plasma genotyping to predict treatment benefit in patients with non-small-cell lung cancer (NSCLC) is confirmed in three studies presented at the European Lung Cancer Conference...
Gene editing could stop cancer cells escaping the immune system
4/15/2016
Cutting off a sleep-switch on immune cells inside a tumour wakes up the cells and enables the immune system to hunt down and destroy the disease, according to a new Cancer Research UK-funded study...
Drop in cigarette smoking linked to decline in prostate cancer deaths
4/14/2016
Declines in prostate cancer deaths from 1999 through 2010 parallel declines in the number of men who smoke cigarettes, Johns Hopkins researchers report.
Led by researchers at the University of Pittsburgh School of Medicine, an international panel of pathologists and clinicians has reclassified a type of thyroid cancer to reflect that it is...
Cancer cells turn healthy cells to the 'dark side'
4/14/2016
Cancer cells use a mutant gene to coerce neighbouring healthy tissue into helping with the disease's growth and spread, a major new study reports.
Immunotherapy with live bacterium improves response rate in malignant pleural mesothelioma
4/14/2016
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and 59% response rate in patients with malignant pleural mesothelioma (MPM), according to...
Incidence of diagnosed thyroid cancer may be leveling off
4/14/2016
In a study published online by JAMA Otolaryngology-Head & Neck Surgery, Luc G. T. Morris, M.D., M.Sc.
Hepatitis C may raise risk of certain head and neck cancers
4/14/2016
For the first time, researchers have found that patients with hepatitis C may be two to five times more likely to develop some cancers of the head and neck.
Neratinib plus paclitaxel vs. trastuzumab plus paclitaxel in breast cancer
4/14/2016
While neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel as first-line treatment for ERBB2-positive metastatic breast cancer in terms of progression-free survival, the...